急性胰腺炎微循环障碍的发生机制及其治疗进展

侯斐; 刘瑞霞; 阴赪宏

doi:10.3969/j.issn.1001-5256.2014.08.033

急性胰腺炎微循环障碍的发生机制及其治疗进展

DOI: 10.3969/j.issn.1001-5256.2014.08.033

1. 首都医科大学附属北京友谊医院感染内科
2. 首都医科大学附属北京妇产医院内科

基金项目:

北京市自然科学基金资助项目(7142044)；

详细信息

中图分类号: R657.51
计量
- 文章访问数: 2868
- HTML全文浏览量: 16
- PDF下载量: 591
- 被引次数: 0
出版历程
- 收稿日期: 2014-07-14
- 出版日期: 2014-08-20

Pathogenetic mechanism of microcirculatory disturbance and treatment advances in acute pancreatitis

Department of Infection, Beijing Friendship Hospital, Capital Medical University

Research funding:

摘要

摘要: 近年来,越来越多的研究表明,血管收缩、血液分流、灌注不足、血液黏滞度增加以及血液凝固等微循环障碍与急性胰腺炎(AP)的发病机制密切相关。缺血再灌注损伤及氧自由基的不断产生亦可加速AP的进程。介绍了胰腺微循环的解剖学特征、胰腺微循环障碍的病理生理学机制及相关的炎症介质,以及AP微循环障碍的治疗进展,提示胰腺及全身微循环障碍可能在AP发生发展中起着重要的作用。
- 急性胰腺炎 /
- 微循环 /
- 解剖学 /
- 病理过程 /
- 炎症趋化因子类 /
- 治疗学 /
- 综述
Abstract: In recent years, there has been increasing evidence that microcirculatory disturbance, including vasoconstriction, shunting, inadequate perfusion, increased blood viscosity, and coagulation, is closely associated with the pathogenesis of acute pancreatitis (AP) .These processes may be exacerbated by ischaemia- reperfusion injury and the generation of oxygen radicals.The anatomical features of pancreatic microcirculation, the pathophysiological mechanism of pancreatic microcirculation disturbance and related inflammatory mediators, and progress in the treatment of microcirculatory disturbance in AP are reviewed.It is suggested that the pancreatic and systemic microcirculation may play a key role in the development and progression of AP.
- acute pancreatitis /
- microcirculation /
- anatomy /
- pathologic processes /
- chemokines /
- therapeutics /
- review

HTML全文

参考文献(40)

[1]SAND J, NORDBACK I.Acute pancreatitis:risk of recurrence and late consequences of the disease[J].Nat Rev Gastroenterol Hepatol, 2009, 6 (8) :470-477.

[2]WHITCOMB DC.Clinical practice.Acute pancreatitis[J].N Engl J Med, 2006, 354 (20) :2142-2150.

[3]YADAV D, LOWENFELS AB.The epidemiology of pancreatitis and pancreatic cancer[J].Gastroenterology, 2013, 144 (6) :1252-1261.

[4]MITCHELL RM, BYRNE MF, BAILLIE J.Pancreatitis[J].Lancet, 2003, 361 (9367) :1447-1455.

[5]PLUSCZYK T, WITZEL B, MENGER MD, et al.ETA and ETB receptor function in pancreatitis-associated microcirculatory failure, inflammation, and parenchymal injury[J].Am J Physiol Gastrointest Liver Physiol, 2003, 285 (1) :g145-g153.

[6]TAKEDA K, MIKAMI Y, FUKUYAMA S, et al.Pancreatic ischemia associated with vasospasm in the early phase of human acute necrotizing pancreatitis[J].Pancreas, 2005, 30 (1) :40-49.

[7]ZHANG XP, LI ZJ, ZHANG J.Inflammatory mediators and microcirculatory disturbance in acute pancreatitis[J].Hepatobiliary Pancreat Dis Int, 2009, 8 (4) :351-357.

[8]KOH YY, JEON WK, CHO YK, et al.The effect of intestinal permeability and endotoxemia on the prognosis of acute pancreatitis[J].Gut Liver, 2012, 6 (4) :505-511.

[9]DABROWSKI A, OSADA J, DABROWSKA MI, et al.Increased expression of the intercellular adhesion molecule-1 (ICAM-1) on peripheral blood neutrophils in acute pancreatitis[J].Adv Med Sci, 2014, 59 (1) :102-107.

[10]ROUDEBUSH WE, WILD MD, MAGUIRE EH.Expression of the platelet-activating factor receptor in human spermatozoa:differences in messenger ribonucleic acid content and protein distribution between normal and abnormal spermatozoa[J].Fertil Steril, 2000, 73 (5) :967-971.

[11]ZHAO YF, ZHAI WL, ZHANG SJ, et al.Protection effect of triptolide to liver injury in rats with severe acute pancreatitis[J].Hepatobiliary Pancreat Dis Int, 2005, 4 (4) :604-608.

[12]POORAN N, INDARAM A, SINGH P, et al.Cytokines (IL-6, IL-8, TNF) :early and reliable predictors of severe acute pancreatitis[J].J Clin Gastroenterol, 2003, 37 (3) :263-266.

[13]KIHARA Y, YOSHIKAWA H, HONDA H, et al.Natural disruption of group 2 phospholipase A2 gene protects against choline-deficient ethionine-supplemented diet-induced acute pancreatitis and lung injury[J].Pancreas, 2005, 31 (1) :48-53.

[14]DIMAGNO MJ, WILLIAMS JA, HAO Y, et al.Endothelial nitric oxide synthase is protective in the initiation of caerulein-induced acute pancreatitis in mice[J].Am J Physiol Gastrointest Liver Physiol, 2004, 287 (1) :g80-g87.

[15]ARMSTRONG JA, CASH N, SOARES PM, et al.Oxidative stress in acute pancreatitis:lost in translation?[J].Free Radic Res, 2013, 47 (11) :917-933.

[16]GERASIMENKO JV, GERASIMENKO OV, PETERSEN OH.The role of Ca2+in the pathophysiology of pancreatitis[J].J Physiol, 2014, 592 (Pt 2) :269-280.

[17]ZAHEER A, SINGH VK, QURESHI RO, et al.The revised Atlanta classification for acute pancreatitis:updates in imaging terminology and guidelines[J].Abdom Imaging, 2013, 38 (1) :125-136.

[18]LENG F, YANG L, CHANG ZG, et al.Classification for acute pancreatitis-2012:revision of the Atlanta classification and definitions by international consensus[J].J Clin Hepatol, 2013, 29 (4) :Ⅰ-Ⅶ. (in Chinese) 冷芳, 杨力, 常志刚, 等.急性胰腺炎分类——2012:亚特兰大分类和定义修订的国际共识[J].临床肝胆病杂志, 2013, 29 (4) :Ⅰ-Ⅶ.

[19]KOKSOY FN, YANKOL Y, SEN OE, et al.Preventive effects of enoxaparin and hesperidin in cerulein-induced acute pancreatitis in rats[J].Turk J Gastroenterol, 2013, 24 (6) :495-501.

[20]LI S, CHEN X, WU T, et al.Role of heparin on serum VEGF levels and local VEGF contents in reducing the severity of experimental severe acute pancreatitis in rats[J].Scand J Gastroenterol, 2012, 47 (2) :237-244.

[21]QIU F, LU XS, HUANG YK.Protective effect of low-molecularweight heparin on pancreatic encephalopathy in severe acute pancreatic rats[J].Inflamm Res, 2012, 61 (11) :1203-1209.

[22]UHLMANN D, LAUER H, SERR F, et al.Pathophysiological role of platelets in acute experimental pancreatitis:influence of endothelin A receptor blockade[J].Cell Tissue Res, 2007, 327 (3) :485-492.

[23]MARTIGNONI ME, CEYHAN GO, AYUNI E, et al.Endothelin receptor antagonists are not beneficial in the therapy of acute experimental pancreatitis[J].Langenbecks Arch Surg, 2004, 389 (3) :184-192.

[24]MANN O, TIEFENBACHER WJ, KAIFI J, et al.Effect of plateletactivating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity[J].Pancreas, 2009, 38 (1) :58-64.

[25]HIRANO T, HIRANO K.Thromboxane A2 receptor antagonist prevents pancreatic microvascular leakage in rats with caerulein-induced acute pancreatitis[J].Int J Surg Investig, 1999, 1 (3) :203-210.

[26]DOBOSZ M, HAC S, MIONSKOWSKA L, et al.Organ microcirculatory disturbances in experimental acute pancreatitis.A role of nitric oxide[J].Physiol Res, 2005, 54 (4) :363-368.

[27]LEINDLER L, MORSCHL E, LASZLO F, et al.Importance of cytokines, nitric oxide, and apoptosis in the pathological process of necrotizing pancreatitis in rats[J].Pancreas, 2004, 29 (2) :157-161.

[28]BLOECHLE C, KUSTERER K, KUEHN RM, et al.Inhibition of bradykinin B2 receptor preserves microcirculation in experimental pancreatitis in rats[J].Am J Physiol, 1998, 274 (1 Pt 1) :g42-g51.

[29]GRIESBACHER T, RAINER I, TIRAN B, et al.Kallikrein inhibitors limit kinin B (2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats[J].Br J Pharmacol, 2008, 155 (6) :865-874.

[30]KECK T, WERNER J, BANAFSCHE R, et al.Oxygen radicals promote ICAM-1 expression and microcirculatory disturbances in experimental acute pancreatitis[J].Pancreatology, 2003, 3 (2) :156-163.

[31]ITO Y, LUGEA A, PANDOL SJ, et al.Substance P mediates cerulein-induced pancreatic microcirculatory dysfunction in mice[J].Pancreas, 2007, 34 (1) :138-143.

[32]ZHANG XP, SHI Y, ZHANG L.Progress in the study of therapeutic effects of traditional Chinese medicine and extracts in treating severe acute pancreatitis[J].JOP, 2007, 8 (6) :704-714.

[33]CAI Z, KNORR D, SMETANSKA I.Enhanced anthocyanins and resveratrol production in Vitis vinifera cell suspension culture by indanoyl-isoleucine, N-linolenoyl-L-glutamine and insect saliva[J].Enzyme Microb Technol, 2012, 50 (1) :29-34.

[34]PIOTROWSKA H, KUCINSKA M, MURIAS M.Biological activity of piceatannol:leaving the shadow of resveratrol[J].Mutat Res, 2012, 750 (1) :60-82.

[35]KARALIS F, SOUBASI V, GEORGIOU T, et al.Resveratrol ameliorates hypoxia/ischemia-induced behavioral deficits and brain injury in the neonatal rat brain[J].Brain Res, 2011, 1425:98-110.

[36]SHA H, MA Q, JHA RK, et al.Resveratrol suppresses microcirculatory disturbance in a rat model of severe acute pancreatitis[J].Cell Biochem Biophys, 2013, 67 (3) :1059-1065.

[37]ANDERSSON E, AXELSSON J, PEDERSEN LC, et al.Treatment with anti-factor VIIa in acute pancreatitis in rats:blocking both coagulation and inflammation?[J].Scand J Gastroenterol, 2007, 42 (6) :765-770.

[38]DU BQ, YANG YM, CHEN YH, et al.N-acetylcysteine improves pancreatic microcirculation and alleviates the severity of acute necrotizing pancreatitis[J].Gut Liver, 2013, 7 (3) :357-362.

[39]NIKFARJAM M, CUTHBERTSON CM, MALCONTENTI-WILSON C, et al.Hyperbaric oxygen therapy reduces severity and improves survival in severe acute pancreatitis[J].J Gastrointest Surg, 2007, 11 (8) :1008-1015.

[40]ONUR E, PAKSOY M, BACA B, et al.Hyperbaric oxygen and Nacetylcysteine treatment in L-arginine-induced acute pancreatitis in rats[J].J Invest Surg, 2012, 5 (1) :20-28.

施引文献

资源附件(0)

访问统计